Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entyvio in Chronic Pouchitis
NCT02790138Phase 4Completed
- Sponsor
- Takeda
- Start
- Oct 2016
- Primary completion
- Jun 2020
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 9
01
Overview
Phase 4, randomised, double-blind trial in pouchitis comparing Vedolizumab IV with Placebo IV (2 arms). Primary endpoint: Percentage of Participants With Chronic or Recurrent Pouchitis Achieving Clinically Relevant Remission at Week 14. Started Oct 2016; status: completed.
02
Drugs
vedolizumab
03
Conditions
pouchitis
Beyond the preview
Go deeper on NCT02790138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02790138.